Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19
The severe respiratory effects of the coronavirus disease 2019 (COVID-19) pandemic have necessitated the immediate development of novel treatments. The majority of COVID-19-related fatalities are due to acute respiratory distress syndrome (ARDS). Consequently, this virus causes massive and aberrant...
Main Authors: | Mohsen Ghiasi, Peyman Kheirandish Zarandi, Abdolreza Dayani, Ali Salimi, Ehsan Shokri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | Regenerative Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320424000476 |
Similar Items
-
A Bibliometric Analysis of Mesenchymal Stem Cell-Derived Exosomes in Acute Lung Injury/Acute Respiratory Distress Syndrome from 2013 to 2022
by: Zhou W, et al.
Published: (2023-07-01) -
New Methods in Cardiac Regenerative Medicine: The Use of Induced Pluripotent Stem Cells, Exosomes, and
Cardiac Patch Technology
by: Abdolreza Dayani, et al.
Published: (2024-08-01) -
Mesenchymal stem cell-derived exosomes for treatment of sepsis
by: Kento Homma, et al.
Published: (2023-04-01) -
Exosomes derived from liver failure patients’ plasma stimulated mesenchymal stem cells alleviate acute liver failure
by: Zhuoran Wang, et al.
Published: (2025-02-01) -
Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
by: Jingwen Jiang, et al.
Published: (2022-03-01)